SCHEMBL11325134

SCHEMBL11325134

Nc1c(Br)ccc2c1CNCCC2

nearest known ligand 0.51

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ PNMT P11086 8/20 0.51
▸ HTR2C P28335 3/20 0.41
▸ HTR2A P28223 2/20 0.41
▸ HTR2B P41595 2/20 0.41
▸ ADRA2A P08913 1/20 0.39
▸ ADRA2B P18089 1/20 0.39
▸ ADRA2C P18825 1/20 0.39
▸ ASIC3 Q9UHC3 1/20 0.36
▸ CD44 P16070 1/20 0.35
▸ CHRM2 P08172 1/20 0.34
▸ CHRM4 P08173 1/20 0.34
▸ CHRM5 P08912 1/20 0.34
▸ CHRM1 P11229 1/20 0.34
▸ CHRM3 P20309 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11338462 0.79 PNMT (0.51) PNMTHTR2CHTR2AHTR2BADRA2A
SCHEMBL11340596 0.79 PNMT (0.70) PNMTHTR2CHTR2AHTR2BADRA2A
SCHEMBL11325747 0.79 PNMT (0.70) PNMTHTR2CHTR2AHTR2BADRA2A
SCHEMBL11335549 0.79 PNMT (0.51) PNMTHTR2CHTR2AHTR2BADRA2A
SCHEMBL11339611 0.79 PNMT (0.51) PNMTADRA2AADRA2BADRA2CCD44
SCHEMBL11344665 0.78 PNMT (0.46) PNMTHTR2CHTR2AHTR2BADRA2A
SCHEMBL11324903 0.78 PNMT (0.51) PNMTADRA2AADRA2BADRA2C
SCHEMBL29573959 0.77 NOS3 (0.39) HTR2CHTR2AHTR2B
SCHEMBL20634317 0.77 NOS3 (0.39) HTR2CHTR2AHTR2B
Hydrochloric Acid SCHEMBL30150929 0.76 NOS3 (0.38) HTR2CHTR2AHTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0002624-B1 2-BENZAZEPINE COMPOUNDS, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM SMITHKLINE BECKMAN CORPORATION (US) 1981-10-14 — — EP disclosed
EP-0002624-A1 2-Benzazepine compounds, processes for their preparation and pharmaceutical compositions containing them SMITHKLINE BECKMAN CORPORATION (US) 1979-06-27 — — EP disclosed
Send feedback